Orphan Canada is a specialty pharmaceutical company that is committed to commercializing therapies for genetic and rare diseases within the Canadian marketplace.
Formed through a partnership with Bourne Partners, Orphan Canada provides research-based companies and licensors with a commercial partner that is uniquely positioned to deliver maximum value to all stakeholders.
Orphan Canada – Website
